Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: The company said it will close the plant in Willowbrook, blaming “inaccurate and unfounded claims regarding Sterigenics and the unstable legislative and regulatory landscape in Illinois.” In August, nearly three dozen people sued Sterigenics, claiming fumes from ethylene oxide, used to sterilize medical equipment at the Willowbrook facility, have adversely affected their health. The Illinois Environmental Protection Agency closed the plant in February, finding that air sampling by town officials and the federal EPA consistently found high outdoor ambient levels of ethylene oxide. Federal regulators consider the gas a carcinogen. Sterigenics, in the past, has said ethylene oxide is the only process to sterilize medical instruments that is federally approved. “Sterigenics appreciates that the state of Illinois has clearly acknowledged the company’s consistent record of regulatory compliance as well as the safety of the new controls we agreed to implement, and we made every effort to reach a constructive resolution,” the company said in the statement announcing the plant’s closing, adding that Illinois’ political environment makes it unwise to operate the plant. Illinois House Republican leader, Rep. Jim Durkin, has been leading a fight against the company’s effort to continue operations outside Chicago. The Legislature is also considering measures that would phase out use of ethylene oxide except in less populated areas. “Sterigenics got the message that we were never going to let them reopen their doors and poison our communities again,” Durkin said in a statement. Illinois Attorney General Kwame Raoul and local officials in July reached an agreement with Sterigenics that would have allowed the plant to reopen after additional emission capture and control equipment was installed. Sterigenics also agreed to fund $300,000 in community projects designed in coordination with the state to benefit the environment and the local community. When that agreement was announced, company President Philip Macnabb said resolution of the matter puts the company a step closer to resuming the work of sterilizing vital medical products and devices for patients in Illinois and beyond. Sterigenics is a division of Ohio-based Sotera Health LLC, which provides safety services to the medical device, pharmaceutical, tissue and food industries. Claim: Chicago-area medical equipment cleaning plant won’t reopen.
[A]: Sterigenics, the medical supply sterilization company that has been battling lawsuits and claims of increased cancer rates from fumes, announced Monday it has decided against reopening its suburban Chicago plant.


[Q]: Paragraph: The significant costs of both drugs were mentioned. Nice job. Good job describing the benefits reported in the two drug studies. The two papers present a bewildering array of statistics. This story did a nice job distilling the information into a couple of very understandable sentences. Good job explaining signifcant potential harms of both drugs – something competitors didn’t do at all. Nice job, including linking (in the online version) to the papers in the New England Journal of Medicine. No disease-mongering of melanoma. Several independent sources cited. The story adequately explained the comparisons between both new drugs and the older dacarbazine chemo drug. Vemurafenib was described as experimental and as “expected to be approved by the FDA within a few months.”  Ipilimumab was explained to be approved in March and already on the market. The relative novelty of both drugs was well explained. It’s clear that the story did not rely on a news release. Claim: Drugs Show Promise Slowing Advanced Melanoma
[A]: The story made strong, clear attempts to report in a restrained manner, using terms/phrases such as:  “notable progress” “do not cure” “might add two to several moths to expected lifespans” “To be sure, more than half of patients with metastatic melanoma would not be helped all that much by either drug.”   Stories about cancer – perhaps especially melanoma because of its treatment challenges – should balance promise with realistic context. This story did a better job of that than the competitors’ efforts we reviewed.


[Q]: Paragraph: Gregory Ferraro was elected Thursday during the board’s meeting at Del Mar racetrack north of San Diego. He was appointed to the governing body five months ago by Gov. Gavin Newsom. Ferraro noted the board has a mandate from Newsom’s office to focus on the health and safety of horses in the wake of 37 horse deaths at Santa Anita since last December. “We have made several important new regulations and changes. There are many more to come,” Ferraro said. “We will gradually eliminate medication. We expect opposition to many of these, but we are determined to carry them out.” Ferraro served as director of the UC Davis School of Veterinary Medicine Center for Equine Health from 1997 to 2014. He owned his veterinary practice from 1972 to 1997. He earned a doctor of veterinary medicine degree from UC Davis and is a member of the American Association of Equine Practitioners and the American Veterinary Medical Association. Ferraro of San Francisco succeeds Chuck Winner, who ended his tenure as board chairman in October. Oscar Gonzales was elected as vice chairman, succeeding Madeline Auerbach, who retired earlier this month. Claim: California Horse Racing Board elects vet as new chairman.
[A]:
The California Horse Racing Board has chosen a longtime veterinarian as its new chairman.